Cook, Andrea J.; Wellman, Robert D.; Nelson, Jennifer C.; … - In: Journal of the Royal Statistical Society Series C 64 (2015) 2, pp. 319-338
type="main" xml:id="rssc12076-abs-0001" <title type="main">Summary</title> <p>Post-market medical product surveillance is important for detecting rare adverse events that are not identified during preapproval. The goal of surveillance is to assess over time for elevated rates of adverse events for new medical products. These...</p>
